Examples of using Postmenopausal in English and their translations into Hungarian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
Raloxifene is also used to lower chances of having invasive breast cancer in postmenopausal women with osteoporosis or at high risk of having invasive breast cancer.
This should be considered when prescribing Senshio for postmenopausal women with a history of stroke
Epimedium flavonoids prevented bone loss in postmenopausal women during a study noted by the MSKCC,
The drug was developed as a new adjunct treatment for operable breast cancer in postmenopausal female patients,
one study looked at a group of postmenopausal women and the impact of this supplement on health.
In a phase I/II dose escalation trial, 34 postmenopausal breast cancer patients,
Older men and postmenopausal women are most frequently affected,
Pharmacokinetic studies for CE/bazedoxifene were conducted in healthy postmenopausal women who were naturally postmenopausal
The following adverse reaction(ADR) data are based on two placebo-controlled studies involving 2,642 postmenopausal osteoporotic women of whom 1,341 received parathyroid hormone.
Ibandronic acid Accord is for use only by postmenopausal women and must not be taken by women who could still have a baby.
An increased risk of developing probable dementia in postmenopausal women 65 years of age
The National Osteoporosis Foundation recommends that postmenopausal women with risk factors,
In healthy male volunteers and postmenopausal women, intravenous administration of ranitidine caused an increase in ibandronic acid bioavailability of about 20%, probably as a result of reduced gastric acidity.
The Women's Health Initiative estrogen-alone trial included 10,739 postmenopausal women between the ages of 50
Ibandronic acid Accord is prescribed to you to treat postmenopausal osteoporosis because you have an increased risk of fractures.
Since women with menopause and postmenopausal women are at higher risk for weight gain
men between 40 and 50 years old and in postmenopausal women.
Study results show that 14 weeks of supplementation produced a significant reduction in pain associated with age-related osteoarthritis as well as boosted the perception of well-being in postmenopausal women(18).
The clinically most important adverse reactions reported in postmenopausal women treated with Evista were venous thromboembolic events(see section 4.4),
The histological analysis of bone biopsies after two and three years of treatment of postmenopausal women showed bone of normal quality and no indication of a mineralization defect.